Accendra Health, Inc. (ACH)

NYSE: ACH · Wholesale-Medical, Dental & Hospital Equipment & Supplies · Glen Allen, VA · filing with the SEC since 1994

Full chart Alerts Compare

Grade3.0

◀ Past 1.8● Present 3.1▶ Future 3.7

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

The companyfiscal 2025, as filed

Revenue$2.76B+3.1%

Net income-$1.10B-203.5%

Earnings per share$-14.31-202.5%

Operating cash flow-$102M-163.0%

Cash$282M+922.7%

Debt$1.80B+0.1%

Shareholders’ equity-$461M-178.6%

Shares, diluted76.9M+0.2%

Return on equityn/a

The recordfrom its filings

Filings in 202660

Newest filingNov 12 · SCHEDULE 13G

Annual reportFeb 20, 2026

Quarterly reportNov 6, 2026

Next report due10-K by Mar 1

Insider sales, 12 months$0.00

Insider buys, 12 months$0.00

Patents grantedn/a

Filer categoryLarge accelerated filer

Trailing twelve months to Sep 2026Revenue $2.55BNet income -$172MCash from operations -$25.3Mthe four newest filed quarters added

Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.

Revenue and net income by fiscal yearRevenueNet income

16171819202122232425

As filed, in USD. Nothing here is a forecast.

News

Nov 12, 2026 · SEC EDGAR · Form SCHEDULE 13G

Large holder notice

Open the filing on sec.gov

Nov 6, 2026 · SEC EDGAR · Form 10-Q

Quarterly report

Open the filing on sec.gov

Nov 5, 2026 · SEC EDGAR · Form 8-K

Results released

Open the filing on sec.gov

Nov 4, 2026 · SEC EDGAR · Form 3

Insider holding, initial

Open the filing on sec.gov

Nov 3, 2026 · SEC EDGAR · Form 8-K

Current report

Open the filing on sec.gov

Nov 2, 2026 · SEC EDGAR · Form 8-K

Current report

Open the filing on sec.gov

Oct 30, 2026 · SEC EDGAR · Form 8-K

Current report

Open the filing on sec.gov

Oct 29, 2026 · SEC EDGAR · Form DEF 14A

Proxy statement

Open the filing on sec.gov

Oct 19, 2026 · SEC EDGAR · Form PRE 14A

Preliminary proxy statement

Open the filing on sec.gov

Oct 9, 2026 · SEC EDGAR · Form 8-K

Current report

Open the filing on sec.gov

An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.

SI brieffrom the record

Core business

Accendra Health, Inc. is classed by the SEC under Wholesale-Medical, Dental & Hospital Equipment & Supplies (industry code 5047), based in Glen Allen, VA. Diabetes Product was 28% of fiscal 2025 revenue.

Newest on the record

Large holder notice on Nov 12. Before it, quarterly report on Nov 6.

What is due next

The 10-K for the period to Dec 31, 2026, due by Mar 1, 2027.

About ACH

Accendra Health, Inc. is classed by the SEC under Wholesale-Medical, Dental & Hospital Equipment & Supplies (industry code 5047), based in Glen Allen, VA. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $2.8 billion and a loss of $1.1 billion (its filed statements).

IndustryWholesale-Medical, Dental & Hospital Equipment & Supplies

HeadquartersGlen Allen, VA

Business modelDistribution business

ExchangeNYSE

Filing since1994

Fiscal year endsDec 31

SEC number (CIK)75252

Peers on fileRYZ, MSM, AIT, SITE

Who runs it

Financial performance

In fiscal 2025 Accendra Health’s revenue was $2.76 billion, up 3.1% from $2.68 billion the year before. It made a net loss of $1.10 billion.

Annual report, filed Feb 20, 2026.

Financial statements

The grade

Accendra Health grades 3.0 of 10 against its own industry, the 51 companies in Wholesale-Medical, Dental & Hospital Equipment & Supplies. All nine metrics are read as filed.

◀ Past1.8

● Present3.1

▶ Future3.7

How the grade is made

Forecast

Every forecast is registered before the outcome, with the rule that settles it. A miss stays on the page.

Company forecasts

SI Assistanton ACH · research, not advice